Vineet Laboratories Ltd

AI

Vineet Laboratories Ltd

₹ 35.5 -3.37%
21 Sep - close price
About

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

Key Points

Business Overview[1]
The Co. manufactures and distributes pharmaceuticals, bulk drugs, chemicals, and pesticides. The company also conducts R&D across the biotechnology, healthcare, and industrial sectors, specializing in the export and import of various chemical formulations.

  • Market Cap 68.9 Cr.
  • Current Price 35.5
  • High / Low 43.8 / 28.0
  • Stock P/E 62.0
  • Book Value 23.8
  • Dividend Yield 0.00 %
  • ROCE 8.49 %
  • ROE 3.68 %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -24.6% over past five years.
  • Promoter holding is low: 5.98%
  • Company has a low return on equity of -22.7% over last 3 years.
  • Promoter holding has decreased over last 3 years: -32.7%
  • Working capital days have increased from 26.7 days to 89.0 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
57.20 37.52 43.37 32.65 37.05 23.86 18.96 18.10 14.08 7.44 17.42 15.65 18.89
51.39 37.26 39.20 33.29 33.63 24.65 19.27 22.23 25.12 7.13 14.24 13.17 16.40
Operating Profit 5.81 0.26 4.17 -0.64 3.42 -0.79 -0.31 -4.13 -11.04 0.31 3.18 2.48 2.49
OPM % 10.16% 0.69% 9.61% -1.96% 9.23% -3.31% -1.64% -22.82% -78.41% 4.17% 18.25% 15.85% 13.18%
0.03 0.03 0.01 0.01 0.41 0.37 0.20 0.03 1.38 0.02 0.01 0.05 0.03
Interest 0.37 0.96 1.02 1.08 1.72 1.14 0.99 0.95 0.90 0.61 2.19 1.09 0.99
Depreciation 0.62 0.61 0.61 0.63 0.67 0.61 0.62 0.62 0.66 0.63 0.63 0.63 0.54
Profit before tax 4.85 -1.28 2.55 -2.34 1.44 -2.17 -1.72 -5.67 -11.22 -0.91 0.37 0.81 0.99
Tax % 26.80% -2.34% 4.71% -11.11% -34.03% -1.84% 6.98% 0.53% -6.24% -4.40% -8.11% -3.70% 27.27%
3.55 -1.25 2.42 -2.07 1.92 -2.13 -1.83 -5.71 -10.53 -0.87 0.40 0.85 0.73
EPS in Rs 1.85 -0.65 1.26 -1.08 1.00 -1.11 -0.95 -2.97 -5.48 -0.45 0.21 0.44 0.38
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.00 243.48 191.10 212.29 150.59 75.00 59.40
0.01 235.33 177.94 204.63 143.39 91.28 50.91
Operating Profit -0.01 8.15 13.16 7.66 7.20 -16.28 8.49
OPM % 3.35% 6.89% 3.61% 4.78% -21.71% 14.29%
0.00 0.39 0.29 0.12 0.46 1.99 0.10
Interest 0.00 2.67 2.09 3.38 4.78 3.98 4.89
Depreciation 0.00 1.81 2.02 2.37 2.52 2.50 2.41
Profit before tax -0.01 4.06 9.34 2.03 0.36 -20.77 1.29
Tax % 0.00% 56.16% 28.91% 38.42% -183.33% -2.79% 13.18%
-0.01 1.78 6.64 1.25 1.03 -20.19 1.11
EPS in Rs -0.11 0.93 3.46 0.65 0.54 -10.52 0.58
Dividend Payout % 0.00% 0.00% 13.89% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -25%
3 Years: -35%
TTM: -21%
Compounded Profit Growth
10 Years: %
5 Years: -9%
3 Years: -4%
TTM: 105%
Stock Price CAGR
10 Years: %
5 Years: -11%
3 Years: -6%
1 Year: 20%
Return on Equity
10 Years: %
5 Years: -8%
3 Years: -23%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.41 9.22 9.22 9.22 9.22 9.22 19.21
Reserves -0.01 17.40 24.00 24.46 25.51 5.43 26.40
0.00 12.48 26.51 31.09 44.30 40.05 45.33
0.00 69.64 73.59 51.08 37.84 39.84 33.84
Total Liabilities 0.40 108.74 133.32 115.85 116.87 94.54 124.78
0.00 19.67 21.38 26.65 26.92 25.46 24.24
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.12 0.14 0.13 0.18 0.21 0.19
0.40 88.95 111.80 89.07 89.77 68.87 100.35
Total Assets 0.40 108.74 133.32 115.85 116.87 94.54 124.78

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.00 27.49 7.63 -9.62 -6.61 11.49 -12.03
0.00 -7.81 -3.68 -6.69 -2.22 -3.18 -1.11
0.00 18.62 11.96 0.27 8.43 -8.23 29.74
Net Cash Flow 0.00 38.30 15.91 -16.03 -0.40 0.08 16.60
Free Cash Flow 0.00 27.49 7.63 -17.25 -9.40 10.44 -13.23
CFO/OP 0% 327% 82% -87% -88% -71% -144%

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 64.03 69.14 60.45 76.59 64.48 70.05
Inventory Days 73.12 109.19 97.79 158.26 259.67 606.03
Days Payable 114.08 161.20 73.90 103.37 174.65 239.52
Cash Conversion Cycle 23.07 17.13 84.34 131.48 149.50 436.56
Working Capital Days 14.41 -19.46 20.63 28.48 -37.28 88.98
ROCE % 34.08% 23.13% 8.69% 6.65% -27.95% 8.49%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Export Revenue as % of Total Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees on Roll
count
Related Party Sales as % of Total Revenue
%
Number of Production Batches
count
Number of Products Manufactured
count
Total Dispatched Volume
kg

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

6 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
38.66% 37.55% 37.50% 37.50% 36.07% 35.85% 35.85% 29.26% 15.89% 12.46% 5.98% 5.98%
0.00% 0.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.36% 0.50%
61.34% 62.20% 62.50% 62.49% 63.93% 64.15% 64.15% 70.74% 84.11% 87.54% 93.67% 93.52%
No. of Shareholders 9,4699,5149,6389,52310,30010,05810,0259,9889,68210,0039,9299,901

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents